摘要
分析抗病毒治疗在乙型肝炎病毒相关肝细胞癌的综合治疗中所起的作用。随着肝细胞癌治疗模式的转变,目前认为抗HBV治疗是HCC综合治疗的重要组成部分,应针对患者进行个体化、优化的多学科综合治疗,选择合适的高效、低耐药、低副作用的抗病毒药物,才能达到提高患者生活质量和延长生存时间的目的。
To review the current situation of antiviral treatment in the patients with HBV related hepatoeellular carcinoma. As the change of treatment mode in the patients with HBV related hepatoeellular carcinoma, it is universally acknowledged that anti-- HBV treatment is very important part of combined therapy for HCC. Individualized and optimal multiple modai- ity therapy should be selected to treat these patients with HBV related HCC. Anti--HBV drug with high efficiency, low resistance and low adverse drug reactions should be selected. Thus patients" quality of life would be improved and the survival time would be prolonged.
出处
《医学与哲学(B)》
2012年第1期34-35,47,共3页
Medicine & Philosophy(B)
关键词
乙型肝炎病毒
肝细胞癌
抗病毒治疗
hepatitis B virus, hepatocellular carcinoma, antiviral treatment